Biostatistics as a science of modelling and analysis of quantifiable biomedical processes and phenomena opens up a wide range of applications from prevention, treatment of environmental risks, consumer protection, health care, research and development, regulatory review and approval to health care reform. National and European laws and directives are creating a growing need. In order to meet this demand, the University of Bremen has established the international Master's programme Medical Biometry/Biostatistics. The aim of the course is to enable students to independently carry out scientific work in medical biometry, as for example the statistical planning and evaluation of empirical studies and the mathematical modelling of correlations in biology and medicine.

The program is offered each two years in English and deepens the basic knowledge of mathematics and statistics from the previous bachelor's program. It extends the knowledge and skills of the students especially in the field of medical research. It places emphasis on interdisciplinarity and practical relevance. A broad spectrum of knowledge for the professional profile of biostatisticians is acquired. Not only practical skills for planning and evaluating empirical studies are taught, but also methodological and medical basics as well as legal and ethical aspects.

An internship is integrated, e.g. in institutes, companies, authorities or clinics, in which the students experience work situations and work requirements in a relevant professional field. Students are familiarised with the current state of research in methodology and application through these offers. Care is taken to ensure that students can exchange information, ideas and problems at a high scientific level in interdisciplinary teams and take responsibility for solutions.

Career perspectives

Excellent career opportunities are opened up for graduates by the objective of the initiative (training of biostatisticians, in particular for clinical research) in a national and international environment in the following areas:

• Health authorities, regulatory agencies, etc.
• University research institutions
• Pharmaceutical industry
• Medical technology industry
• CROs (companies that specialize in conducting clinical trials as service providers)